Brain inflammatory thrombogenic vasculopathy related with SARS-CoV-2 infection

Brain inflammatory thrombogenic vasculopathy related with SARS-CoV-2 infection

Bibliographic Details
Main Authors:	J. Porta-Etessam, M. Yus, N. González García, A. Valcarcel, J. Barrado-Cuchillo, J. Pérez-Somarriba
Format:	Article
Language:	English
Published:	Elsevier España 2020-11-01
Series:	Neurología (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2173580820302236

Similar Items

Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
by: Nazzarena Labò, et al.
Published: (2020-06-01)

OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection
by: S. Santos-Lasaosa, et al.
Published: (2020-06-01)

Paraneoplastic Syndrome and SARS-CoV-2—Incremental Effect of 2 Thrombogenic Conditions?Novel Teaching Points
by: Norman Mangner, MD, et al.
Published: (2021-02-01)

Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection—A Cross-Sectional Study
by: Philipp Jud, et al.
Published: (2021-10-01)

Infiltración con onabotulinumtoxinA y bloqueos en el paciente con cefalea y neuralgia: recomendaciones de seguridad frente a la infección por SARS-CoV-2
by: S. Santos-Lasaosa, et al.
Published: (2020-06-01)

Acute testicular infarction in the setting of SARS-CoV-2 infection and diabetic vasculopathy
by: Tenny R. Zhang, et al.
Published: (2023-03-01)

Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
by: J. Matías-Guiu, et al.
Published: (2020-04-01)

Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices
by: Carlos A. Labarrere, et al.
Published: (2020-03-01)

Anti-Inflammatory and Anti-Thrombogenic Properties of Arterial Elastic Laminae
by: Jeremy Goldman, et al.
Published: (2023-03-01)

Direct endothelial ENaC activation mitigates vasculopathy induced by SARS-CoV2 spike protein
by: Maritza J. Romero, et al.
Published: (2023-08-01)

Isradipine decreases arterial thrombogenicity in rabbits
by: P Fitscha, et al.
Published: (2001-01-01)

Anti-thrombogenicity by Layer-by-Layer
by: Shiratori Seimei, et al.
Published: (2013-08-01)

SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease
by: Yuhai Zhao, et al.
Published: (2022-06-01)

Thrombogenic responses from electrocured tissue adhesives
by: Nanda, Himansu Sekhar, et al.
Published: (2019)

A macrofluidic model to investigate the intrinsic thrombogenicity of clinically used stents and develop less thrombogenic stents
by: Axelle Y. Kern, et al.
Published: (2024-03-01)

Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation
by: Alexander E. Berezin, et al.
Published: (2022-02-01)

THROMBOGENICITY OF SHUNGITE CARBON NANOPARTICLES IN VITRO
by: Alexandra Borisova
Published: (2018-06-01)

Nanomedicine for the reduction of the thrombogenicity of stent coatings
by: Varvara C Karagkiozaki, et al.
Published: (2010-03-01)

Immune Profile of SARS-CoV-2 Variants of Concern
by: Caterina A. M. La Porta, et al.
Published: (2021-07-01)

Indomethacin & SARS-CoV-2: Prospects for clinical management of the inflammatory state
by: Satyanath R. Kodidala, et al.
Published: (2021-12-01)

Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease
by: M. D. Martin-Arranz, et al.
Published: (2023-04-01)

Autophagy in Inflammatory Response against SARS-CoV-2
by: Roxana Resnik, et al.
Published: (2023-03-01)

The Impact of SARS-CoV-2 on Inflammatory Bowel Disease
by: Maria Manuela Estevinho, et al.
Published: (2020-05-01)

Thrombogenicity studies on micro/nano topographic surfaces
by: Koh, Li Buay
Published: (2010)

Seasonality of thrombogenic disorders in coronary atherosclerosis recrudescence
by: Liliana K. Tokaeva, et al.
Published: (2012-09-01)

SARS-CoV-2 infection and the brain: direct evidence for brain changes in milder cases
by: Nico Sollmann, et al.
Published: (2022-07-01)

Encephalopathy in severe SARS-CoV2 infection: Inflammatory or infectious?
by: María José Abenza-Abildúa, PhD, et al.
Published: (2020-09-01)

SARS-CoV-2 Spike Proteins and Cell–Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis
by: Biju Bhargavan, et al.
Published: (2022-09-01)

Herpesviruses and SARS-CoV-2: Viral Association with Oral Inflammatory Diseases
by: Jonathan M. Banks, et al.
Published: (2024-01-01)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
by: Rajat Goyal, et al.
Published: (2022-09-01)

Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
by: Huan Zhou, et al.
Published: (2021-12-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

Interactions of SARS-CoV-2 with the Blood–Brain Barrier
by: Michelle A. Erickson, et al.
Published: (2021-03-01)

SARS-CoV-2 Attacks in the Brain: Focus on the Sialome
by: Przemyslaw Wielgat, et al.
Published: (2022-04-01)

Vision, brain, and nerves affected by SARS-CoV-2
by: Josef Finsterer
Published: (2023-01-01)

SARS-CoV-2, the blood-brain barrier, and neuroinflammation
by: William A Banks, MD
Published: (2023-04-01)

396 Brain pathophysiology in SARS-CoV-2 disease
by: Branka Milicic Stanic, et al.
Published: (2022-04-01)

SARS-CoV-2-related Multisystem Inflammatory Syndrome in Adults
by: Antonio Martins, et al.
Published: (2021-11-01)